Yixintang Pharmaceutical Group Co Ltd Announces Dividend Distribution Plan

Yixintang Pharmaceutical Group Co., Ltd., a prominent player in the pharmaceutical retail sector based in Kunming, China, has recently announced a dividend distribution plan for the 2024 fiscal year. The company, which operates a network of pharmaceutical stores retailing Chinese and western medicines, as well as medical equipment, will distribute a cash dividend of 3.00 yuan per share to all shareholders. The record date for this dividend is set for June 3rd.

This announcement has positively impacted the company’s stock performance. On May 26th, Yixintang’s shares opened higher by 2.79%, reflecting investor optimism following the dividend declaration. The company’s stock price, which closed at 18.85 CNH on May 25th, 2025, has been influenced by both the dividend news and broader market trends. The pharmaceutical sector has experienced a surge, contributing to the upward movement in Yixintang’s stock price.

Yixintang Pharmaceutical Group Co., Ltd. is listed on the Shenzhen Stock Exchange and operates within the Consumer Staples Distribution & Retail industry. The company’s market capitalization stands at 10,120,000,000 CNH, with a price-to-earnings ratio of 336.25. Over the past year, the stock has seen significant fluctuations, reaching a 52-week high of 21.04 CNH on May 30, 2024, and a low of 10.84 CNH on September 17, 2024.

For more information, stakeholders and interested parties can visit the company’s website at www.hx8886.com . The dividend distribution plan underscores Yixintang’s commitment to returning value to its shareholders while continuing to expand its presence in the pharmaceutical retail market.